Berberine 4x combines Berberine with Eucommia and Chromium Picolinate to support normal glucose levels, cholesterol levels and cardiovascular health. When Berberine is suspended in healthy oils, it is protected and provides 4x greater bioavailability through our Omega Absorb™ delivery system.

• Supports normal glucose levels
• Supports heart health and normal cholesterol levels
• Vegan friendly
• 4x greater bioavailability
• Made with Omega Absorb™ delivery system

Triple action support with Berberine, Eucommia & Chromium Picolinate

Berberine

Berberine 4x contains 1,000 mg of Berberine per daily dose, which is clinically proven to support healthy blood glucose levels.

Berberine helps the body to respond better to glucose by inducing insulin secretion, reducing insulin resistance, and improving insulin sensitivity in the liver, muscles and fat tissues.¹

Berberine also helps drive sugar into the muscle and liver helping to increase energy during exercise, promoting fat-loss and reducing muscle damage with high-intensity exercise. Studies show Berberine may help improve cholesterol profile.²

Eucommia

Eucommia inhibits glycation. Glycation is when sugar is bound to a protein making the protein not functional, which can lead to heart disease.³

Chromium Picolinate

Chromium picolinate has been shown to help support normal blood sugar levels by facilitating the uptake of glucose into cells. Chromium picolinate may also help improve insulin sensitivity, allowing cells to effectively respond to insulin and uptake glucose efficiently.

4x Bioavailability with Omega Absorb ™ delivery system

Through the power of healthy oils, our award-winning delivery system allows our bodies to absorb the nutrients it need to improve our health and achieve our wellness goals. The body poorly absorbs Berberine, however, when suspended in healthy oils using our Omega Absorb ^™ delivery system it has 4x greater bioavailability.⁴

References:
1. Cao C. et el (2019) Experimental and Therapeutic Medicine 17:3009-30014
2. Cesarone, MR et al (2023) Minerva Gastroenterol Oct 19, Hernandez, AV et al (2023) J Dietary Suppl https://doiorg/10.1080/19390211.2023.2212762
3. Sugawa H et al (2016) Food and Function 7: 2566-2575, Xu H. et al (2019) Colloids and Surfaces B: Biointerfaces (181): 927-934, Young Kim H et al (2004) J Ethnopharmacol 93: 227-230) Sugawa H et al (2016) Food and Function 7: 2566-2575
4. Xu H. et al (2019) Colloids and Surfaces B: Biointerfaces 181: 927-934, 5. Firouzi S. et al (2018) Diabetes, Metabolic Sydrome and Obesity: Targets and Therapy 11:699-705, Yan H.M et al (2025) PLoS One 10(8): DOI:10.1371/journal.pone.0134172

Key Ingredients